Akari Therapeutics Stock Target Price and Analyst Consensus
| AKTX Stock | USD 1.14 0.11 10.68% |
The current analyst and expert consensus on Akari Therapeutics is Strong Buy, with only one strong buy opinion. The current projected Akari Therapeutics target price consensus is 55.00 with 1 analyst opinions. Check out Macroaxis Advice on Akari Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Akari Therapeutics PLC analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Akari Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Akari Therapeutics. We encourage you to use your own analysis of Akari Therapeutics PLC to validate this buy or sell advice. Akari Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Akari Therapeutics PLC target price to derive its highest and lowest estimates based on projected price volatility of 6.9706.
Lowest Forecast 50.05 | Highest Forecast 61.05 | Target Price 55 |
Akari |
It's important to approach Akari Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Akari Therapeutics price targets
Akari Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Akari Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Akari Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Akari Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Akari Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Akari Therapeutics is a key component of Akari Therapeutics valuation and have some predictive power on the future returns of a Akari Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Akari Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Entertainment Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Investor Favorites Invested over 60 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Warren Buffett Holdings Invested over 40 shares | |
 | Cash Cows Invested few shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Business Services Invested few shares | |
 | Momentum Invested over 60 shares | |
Additional Tools for Akari Stock Analysis
When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.